L7 | Webinars and Industry Presentations

In this webinar, experts from L7 Informatics and SciBite explore how integrated platforms help organizations prepare their data for AI,

In this short recording, Kevin McMahon, Ph.D., Solutions Consulting, Therapeutics Lead at L7 Informatics, gives an overview of L7 and

In this webinar, Vasu Rangadass, Ph.D., CEO at L7 Informatics, explores how the L7|ESP unified platform can support the Hub

In this webinar, Dr. Ray Veeraraghavan, the Executive Director for Technology and Molecular Genomics and Oncology at Quest Diagnostics, provides

Over the past year, Dana-Farber Cancer Institute's Connell and O'Reilly Families Cell Manipulation Core Facility has been on an exciting

Imagine a world where identifying a pathogen in a clinical sample isn't a painstaking wait for cultures to grow, and

This webinar describes Think Bioscience’s novel platform, explores their successful collaboration with Boulder BioConsulting, and elaborates on the process used

Helen Pye, Manager at QIAGEN, dives into how QIAGEN has been successful in using L7|ESP and customizing it to their

Arvind Ramakrishnan, Vice President of Customer Solutions – Research & Diagnostics at L7 Informatics leads a captivating discussion where panelists

In this panel discussion moderated by Marcia Blackmoore, L7 Informatics' VP of Customer Solutions Therapeutics, panelists share approaches and challenges

L7 Informatics' President and CEO, Vasu Rangadass, Ph.D., discusses how L7 Informatics' fully digitalized platform, L7|ESP, enables the much-needed growth

Join Vasu Rangadass, CEO & President at L7 Informatics, as he discusses achieving operational excellence in Life Sciences using digital

Explore the potential of "Informatics as a Service" in modern drug discovery, as it provides companies access to a range

Explore the advantages of utilizing a unified platform for managing decentralized manufacturing operations in the era of Industry 4.0. Discover

Explore the challenges and benefits of digitalizing cell and gene therapy laboratory workflows through case studies, revealing improvements in reproducibility,

Discover Tag.bio, a next-generation end-to-end data mesh platform that combines AI/machine learning algorithms with a federated computational layer. Learn how

In this recording, Vasu Rangadass, President and CEO at L7 Informatics, discusses how applying the 4th Industrial Revolution principles can

Vasu Rangadass, President and CEO at L7 Informatics, explores the potential of applying principles from the 4th Industrial Revolution and

After a brief speaker introduction from Jared Fine, Partner at Goodwin, Vasu Rangadass, Ph.D., President & CEO of L7 Informatics,

Dr. Jerome Ritz is the Executive Director of the Connell and O'Reilly Families Cell Manipulation Core Facility at the Dana

Take a closer look at the L7|ESP platform with L7 team members Steven Barash, Head of Strategy & Development, and

Jane Lomax, Ph.D., Head of Ontologies from Scibite, join us for L7|LIVE Boston from the UK! Jane is an ontology

With an industry-wide connected value chain, data is readily available and accessible, which enables informed decision-making and quick reactions to

This workshop discussion explores ways in which advancements in data capture, data interrogation and analytics can improve advanced therapies product

L7's COO, Trent Carrier, PhD, MBA, and other industry leaders are joining the Plenary Discussion Panel "Increasing Control and Security

Vasu Rangadass, Ph.D., L7 Informatics' President and Chief Executive Officer talks about digital transformation, and the benefits of a unified

Joined by industry leaders, Trent Carrier Ph.D., MBA, L7 Informatics' Chief Operating Officer facilitates an interactive discussion regarding the key

Walt Schoenborn, Vice President - Digital Media at ScienceBoard.net, part of Science and Medicine Group, interviews Louis Hendriks, Founder &

L7 President & CEO Vasu Rangadass presents with Sanofi's Yves Fomekong Nanfack in the Digital Lab Track at Lab of

Patrick Rose, Director, Product Management at L7 Informatics, looks at how L7 can enable companies to achieve level 4 of

Karri Unruh, L7's Director of Product Management discusses how digital transformation in Precision Medicine helps address regulatory and compliance demands.

L7 Informatics’ Precision Therapeutics Lead, Kevin McMahon discusses how digitalization can accelerate the identification of neoantigens for use in vaccine

Patrick Rose, Product Management Director at L7, discusses digital transformation of the lab through standardization and automation.

In this talk, L7 Informatics' President and CEO, Vasu Rangadass, Ph.D., discusses a unified platform approach to digitalize operations across

An engaging panel discussion with QIAGEN, L7 Informatics and Johnson & Johnson regarding the digitalization of the lab, including implementation,

Vasu Rangadass, Ph.D., President and CEO of L7, and Dr. Stephen Kingsmore, M.D., DSc, President and CEO of RCIGM, present

Trent Carrier, Ph.D., L7’s Chief Operational Officer, and Richard Love, Senior Data & Bi Architect at L7 Informatics co-present “Trends

L7 Informatics’ President & CEO, Vasu Rangadass, Ph.D. talks about the digitalization journey in life sciences: from research to manufacturing

A tutorial session featuring a case study with L7 Informatics and CRL's Cognate BioServices, followed by a demo of the

An in-depth discussion on digital transformation for advanced therapeutics, supported by a case study with Gradalis, a clinical-stage immunotherapy company.

In this webinar, participants will discuss the automation of all lab operations at the Genome Technology Access Center (GTAC@MGI) in

A discussion with L7's President & CEO, Vasu Rangadass, Ph.D. regarding the streamlining of digital transformation to reduce data and

L7's President & CEO, Vasu Rangadass, Ph.D. takes an in-depth look at the future of the lab and the digitalization

Vasu Rangadass, Ph.D., President and CEO of L7 Informatics, takes an in-depth look at the future of the lab and

Vasu Rangadass, Ph.D., L7 Informatics' President and CEO takes for an in-depth look at the future of the lab and